维普中文期刊产品整合服务
175篇 您的检索式:作者名="Benjamin R M"
    题名 作者 年代 出处 被引量
12018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) 2019中华精神科杂志2019,52,1:25
2Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma显示文摘Glioblastoma multiforme(GBM) is the most common malignant primary brain tumor with a survival prognosis of 14-16 mo for the highest functioning patients. Despite aggressive, multimodal upfront therapies, the majority of GBMs will recur in approximately six months. Salvage therapy options for recurrent GBM(r GBM) are an area of intense research. This study compares recent survival and quality of life outcomes following Gamma Knife radiosurgery(GKRS) salvage therapy. Following a Pub Med search for studies usingGKRS as salvage therapy for malignant gliomas, nine articles from 2005 to July 2013 were identified which evaluated rG BM treatment. In this review, we compare overall survival following diagnosis, overall survival following salvage treatment, progression-free survival, time to recurrence, local tumor control, and adverse radiation effects. This report discusses results for rG BM patient populations alone, not for mixed populations with other tumor histology grades. All nine studies reported median overall survival rates(from diagnosis, range:16.7-33.2 mo; from salvage, range:9-17.9 mo). Three studies identified median progression-free survival(range:4.6-14.9 mo). Two showed median time to recurrence of GBM. Two discussed local tumor control. Six studies reported adverse radiation effects(range:0%-46% of patients). The greatest survival advantages were seen in patients who received GKRS salvage along with other treatments, like resection or bevacizumab, suggesting that appropriately tailored multimodal therapy should be considered with each rG BM patient. However, there needs to be a randomized clinical trial to test GKRS for rG BM before the possibility of selection bias can be dismissed.Erik W Larson Halloran E Peterson Wayne T Lamoreaux Alexander R MacKay Robert K Fairbanks Jason A Call Jonathan D Carlson Benjamin C Ling John J Demakas Barton S Cooke Christopher M Lee 2014World Journal of Clinical Oncology2014,5,2:5
3Late biliary complications in human alveolar echinococcosis are associated with high mortality显示文摘AIM:To evaluate the incidence of late biliary complications in non-resectable alveolar echinococcosis(AE)under long-term chemotherapy with benzimidazoles.METHODS:Retrospective analysis of AE patients with biliary complications occurring more than three years after the diagnosis of AE.We compared characteristics of patients with and without biliary complications,analyzed potential risk factor for biliary complications and performed survival analyses.RESULTS:Ninety four of 148 patients with AE in Zurich had non-resectable AE requiring long-term benzimidazole chemotherapy,of which 26(28%)patients developed late biliary complications.These patients had a median age of 55.5(35.5-65)years at diagnosis of AE and developed biliary complications after 15(8.25-19)years of chemotherapy.The most common biliary complications during long-term chemotherapy were late-onset cholangitis(n=14),sclerosing cholangitis-like lesions(n=8),hepatolithiasis(n=5),affection of the common bile duct(n=7)and secondary biliary cirrhosis(n=7).Thirteen of the 26 patients had undergone surgery(including 12 resections)before chemotherapy.Previous surgery was a risk factor for late biliary complications in linear regression analysis(P=0.012).CONCLUSION:Late biliary complications can be observed in nearly one third of patients with non-resectable AE,with previous surgery being a potential risk factor.After the occurrence of late biliary complications,the median survival is only 3 years,suggesting that late biliary complications indicate a poor prognostic outcome.Pascal Frei Benjamin Misselwitz Meher K Prakash Alain M Schoepfer Bettina M Prinz Vavricka Beat Müllhaupt Michael Fried Kuno Lehmann Rudolf W Ammann Stephan R Vavricka 2014World Journal of Gastroenterology2014,20,19:5
4Inflammatory and anti-inflammatory effects of soybean agglutinin 显示文摘Benjamin C F Fiqueriedo R C Henriques M G et ol 1997Braz J Med Biol Res1997,30,:1
5Adsorption of natural organic matter (NOM) on iron oxide: Effects on NOM composition and formation of organo-halide compounds during chlorination显示文摘Korshin G V Benjamin M M Sletten R S 1997Water Research1997,31,7:1
6NOM removal by slow sand filtration through iron oxide-coated olivine 显示文摘McMeen C R Benjamin M M 1997J AWWA1997,89,2:1
7A structural equations analysis of revealed and stated travel mode and activity choices显示文摘SAKANO R BENJAMIN J M 2008Transportmetrica2008,4,2:1
8Sorption and filtration of metals using iron-oxide-coated sand 显示文摘Benjamin M M Sletten R S 1996Water Res1996,30,11:1
9A method for protocol based collision avoidance between autonomous marine surface craft显示文摘Benjamin M R Leonard J J Curcio J A 2006Journal of Field Robotics2006,23,5:1
10Bone health: Preventing osteoporosis显示文摘Benjamin R M 2010J Am Diet Assoc2010,110,4:1
11The bedside insertion of inferior vena cava filters using ultrasound guidance 显示文摘UPPAL B FLINN W R Benjamin M E 2007Perspect Vasc Surg Endovasc Ther2007,19,1:1
12Distributed surveillance on freeways emphasizing incident detection and verification 显示文摘Benjamin A Coifman R M 2007Transporta- tion Research: Part A2007,,41:1
13Recent trends in the management of combined pancreatoduodenal injuries显示文摘Lopez PP Benjamin R Cockburn M 2005Am Surg2005,71,10:1
14Sterically engineered perylene dyes for high efficiency oriented fluorophore luminescent solar eoncentrators显示文摘Benjamin W E Veit D R Perkins M J 2014Chemistry of Materials2014,26,3:1
15Diagnosis and localization of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimuluation catheterisation显示文摘Maralun R Druce Vasantha M Muthuppalaniappan Benjamin O' Leary 2010European Journal of Endocrinology2010,162,:1
16Computerized occlusal analysis: a new technology 显示文摘Maness Wl Benjamin M Podoloff R 1987Quintessence Int1987,18,4:1
17Inflammatory and anti-inflammatory effects of soybean agglutinin显示文摘BENJAMIN C F FIQUERIEDO R C HENRIQUES M G 1997Braz J Med Biol Res1997,30,:1
18A simple model for complex dynamical transitions in epidemics显示文摘 Pejman R Benjamin M B 2000Science2000,287,:1
19Adsorption of natural organic matter (NOM) on iron oxide: effects on NOM composition and formation of organo-halide compounds during chlorination显示文摘Korshin G V Benjamin M M Sletteh R S 1997Water Research1997,31,7:1
20Computerizedocclusal analysis: a new technology 显示文摘Maness W L Benjamin M PodolofF R 1987Quintessence Int1987,18,4:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费